Literature DB >> 20102944

Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.

Olivier Muller1, Michalis Hamilos, Jozef Bartunek, Hans Ulrichts, Fabio Mangiacapra, Josefin-Beate Holz, Argyrios Ntalianis, Catalina Trana, Karen Dierickx, Kristof Vercruysse, Bernard De Bruyne, William Wijns, Emanuele Barbato.   

Abstract

Platelet reactivity is greater in patients with stable angina and with more extensive peripheral vascular atherosclerosis. We sought to evaluate whether impaired peripheral microcirculatory endothelial function might correlate with platelet reactivity after clopidogrel and therefore predispose to an unfavorable outcome after percutaneous coronary intervention (PCI). In 52 consecutive patients with stable angina undergoing elective PCI, endothelial function was assessed by (1) endothelial peripheral arterial tonometry (measuring the "Endoscore"); (2) the von Willebrandt factor antigen level and ristocetin co-factor activity. Basal platelet reactivity was assessed by soluble P-selectin. Patients then received a 600-mg clopidogrel loading dose > or = 12 hours before PCI. A blood sample was withdrawn 12 hours later, but before PCI, to assess platelet reactivity using the P2Y12 reaction unit and percentage of P2Y12 inhibition with the point-of-care VerifyNow P2Y12 assay. Troponin T was assessed 24 hours after PCI. The Endoscore inversely correlated with von Willebrandt factor antigen activity (r = -0.52, p = 0.0001) and soluble P-selectin concentration (r = -0.36, p = 0.021), suggesting greater platelet reactivity with increased impaired endothelial function. After clopidogrel, the Endoscore correlated directly with the percentage of P2Y12 inhibition (r = 0.36, p = 0.009) and inversely with the P2Y12 reaction unit (r = -0.41, p = 0.002), suggesting greater residual platelet reactivity with more impaired endothelial function. The average Endoscore was significantly lower in patients with troponin T elevation (troponin positive group 0.267 + or - 0.091) than in patients without troponin T elevation (troponin negative group 0.508 + or - 0.041, p = 0.015 vs troponin positive). In conclusion, an impaired endothelial response before clopidogrel was associated with greater platelet reactivity after clopidogrel. This link might explain the unfavorable PCI outcomes in patients with more severe endothelial impairment. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20102944     DOI: 10.1016/j.amjcard.2009.09.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Endothelial dysfunction: its clinical value and methods of assessment.

Authors:  Teresa Strisciuglio; Stefania De Luca; Ernesto Capuano; Rossella Luciano; Tullio Niglio; Bruno Trimarco; Gennaro Galasso
Journal:  Curr Atheroscler Rep       Date:  2014-06       Impact factor: 5.113

Review 2.  Interaction between platelets and endothelium: from pathophysiology to new therapeutic options.

Authors:  Michalis Hamilos; Stylianos Petousis; Fragiskos Parthenakis
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

Review 3.  Clinical implications of platelet-vessel interaction.

Authors:  Fabio Mangiacapra; Emanuele Barbato
Journal:  J Cardiovasc Transl Res       Date:  2012-12-28       Impact factor: 4.132

4.  von Willebrand factor inhibition improves endothelial function in patients with stable angina.

Authors:  Olivier Muller; Jozef Bartunek; Michalis Hamilos; Catalina Trana Berza; Fabio Mangiacapra; Argyrios Ntalianis; Kristof Vercruysse; Christian Duby; William Wijns; Bernard De Bruyne; Guy R Heyndrickx; Marc Vanderheyden; Josefin-Beate Holz; Emanuele Barbato
Journal:  J Cardiovasc Transl Res       Date:  2012-12-12       Impact factor: 4.132

5.  Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel.

Authors:  Michalis Hamilos; Olivier Muller; Argyrios Ntalianis; Catalina Trana; Jozef Bartunek; Giovanna Sarno; Fabio Mangiacapra; Karen Dierickx; Peter Meeus; Thomas Cuisset; Bernard De Bruyne; William Wijns; Emanuele Barbato
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

6.  Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention.

Authors:  Edoardo Bressi; Fabio Mangiacapra; Elisabetta Ricottini; Ilaria Cavallari; Iginio Colaiori; Giuseppe Di Gioia; Antonio Creta; Marialessia Capuano; Michele Mattia Viscusi; Germano Di Sciascio
Journal:  J Cardiovasc Transl Res       Date:  2018-10-01       Impact factor: 4.132

7.  Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: a landmark analysis.

Authors:  Fabio Mangiacapra; Iginio Colaiori; Elisabetta Ricottini; Antonio Creta; Giuseppe Di Gioia; Ilaria Cavallari; Edoardo Bressi; Marialessia Capuano; Emanuele Barbato; Germano Di Sciascio
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

8.  Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial.

Authors:  Emanuele Barbato; Arnold Herman; Edouard Benit; Luc Janssens; Jacques Lalmand; Etienne Hoffer; Patrick Chenu; Antoine Guédès; Luc Missault; Bruno Pirenne; François Cardinal; Steven Vercauteren; William Wijns
Journal:  J Cardiovasc Transl Res       Date:  2013-10-19       Impact factor: 4.132

Review 9.  Novel antiplatelet agents: ALX-0081, a Nanobody directed towards von Willebrand factor.

Authors:  Jozef Bartunek; Emanuele Barbato; Guy Heyndrickx; Marc Vanderheyden; William Wijns; Josefin-Beate Holz
Journal:  J Cardiovasc Transl Res       Date:  2013-01-11       Impact factor: 4.132

10.  Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteers.

Authors:  Craig R Lee; Almasa Bass; Kyle Ellis; Bryant Tran; Savanna Steele; Melissa Caughey; George A Stouffer; Alan L Hinderliter
Journal:  Am J Cardiol       Date:  2011-12-06       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.